These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5655243)

  • 1. Myelofibrosis.
    Malpas JS
    Proc R Soc Med; 1968 May; 61(5):499. PubMed ID: 5655243
    [No Abstract]   [Full Text] [Related]  

  • 2. Myelofibrosis: response to busulfan after hydroxyurea failure.
    Naqvi T; Baumann MA
    Int J Clin Pract; 2002 May; 56(4):312-3. PubMed ID: 12074218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tactics of cytostatic therapy of primary and secondary (post-erythremic) myelofibrosis].
    Demidova AV; Sysoeva NA
    Probl Gematol Pereliv Krovi; 1976 Jul; 21(7):23-7. PubMed ID: 1071792
    [No Abstract]   [Full Text] [Related]  

  • 4. [Indications for cytostatic treatment of patients with osteomyelosclerosis of osteomyelofibrosis].
    Engelmann C; Schulz K; Nowotny P; Konrad H
    Dtsch Gesundheitsw; 1972 Dec; 27(50):2375-80. PubMed ID: 4651200
    [No Abstract]   [Full Text] [Related]  

  • 5. [Myelobromel in the treatment of patients with idiopathic myelofibrosis during erythremic phase].
    Komiva NF
    Probl Gematol Pereliv Krovi; 1970 Jan; 15(1):50-3. PubMed ID: 5420384
    [No Abstract]   [Full Text] [Related]  

  • 6. [Liver damage during use of busulfan].
    Adang RP; Breed WP
    Ned Tijdschr Geneeskd; 1989 Jul; 133(30):1515-8. PubMed ID: 2797253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission of chronic idiopathic myelofibrosis to busulphan treatment.
    Manoharan A
    Am J Med Sci; 1989 Feb; 297(2):133. PubMed ID: 2919633
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of osteomyelosclerosis and osteomyelofibrosis].
    Treske U
    Dtsch Med Wochenschr; 1970 Aug; 95(33):1691-2. PubMed ID: 5447788
    [No Abstract]   [Full Text] [Related]  

  • 9. Evolution of myelofibrosis in chronic idiopathic myelofibrosis as evidenced in sequential bone marrow biopsy specimens.
    Buhr T; Büsche G; Choritz H; Länger F; Kreipe H
    Am J Clin Pathol; 2003 Jan; 119(1):152-8. PubMed ID: 12520711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Bundschuh S; Biermann T; Roessler G; Wasmus M; Diehl V; Zankovich R; Schaefer HE
    Am J Clin Pathol; 2000 Jul; 114(1):57-65. PubMed ID: 10884800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agnogenic myeloid metaplasia. Natural history and treatment.
    Silverstein MN; Gomes MR; ReMine WH; Elveback LR
    Arch Intern Med; 1967 Nov; 120(5):546-50. PubMed ID: 6054588
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of cyclophosphane in the treatment of myelofibrosis].
    Klimova NF; Indosova EN
    Probl Gematol Pereliv Krovi; 1971 Jul; 16(7):11-6. PubMed ID: 5124632
    [No Abstract]   [Full Text] [Related]  

  • 13. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
    Nand S; Stock W; Godwin J; Fisher SG
    Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
    Kumas Sotiris ; Semenova EA; Turkina AG; Zakharova AV; Domracheva EV; Khoroshko ND; Frank GA
    Arkh Patol; 2003; 65(4):9-12. PubMed ID: 14518186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic myelofibrosis associated with dermatomyositis.
    Muslimani A; Ahluwalia MS; Palaparty P; Daw HA
    Am J Hematol; 2006 Jul; 81(7):559-60. PubMed ID: 16755562
    [No Abstract]   [Full Text] [Related]  

  • 16. Myeloablative conditioning in myelofibrosis using i.v. treosulfan and autologous peripheral blood progenitor cell transplantation with high doses of CD34+ cells results in hematologic responses. A follow-up of three patients.
    Fruehauf S; Buss EC; Tropaly J; Kreipe HH; Ho AD
    Haematologica; 2005 Jan; 90(1):ECR08. PubMed ID: 16791927
    [No Abstract]   [Full Text] [Related]  

  • 17. Low-dose thalidomide in myelofibrosis.
    Weinkove R; Reilly JT; McMullin MF; Curtin NJ; Radia D; Harrison CN
    Haematologica; 2008 Jul; 93(7):1100-1. PubMed ID: 18508796
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of cyclosporin-A on anemia in idiopathic myelofibrosis.
    Falcone A; Musto P; Carotenuto M
    Haematologica; 1998 Jul; 83(7):665-6. PubMed ID: 9718875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myleran and damage to spermatozoa in man].
    Eberle P
    Dtsch Med Wochenschr; 1969 Feb; 94(7):347-8. PubMed ID: 5762999
    [No Abstract]   [Full Text] [Related]  

  • 20. The reversal of myelofibrosis associated with chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Oblon DJ; Elfenbein GJ; Braylan RC; Jones J; Weiner RS
    Exp Hematol; 1983 Aug; 11(7):681-5. PubMed ID: 6350032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.